China Tries To Curb Rising TCM Ingredient Prices, But Hikes Persist
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The prices of basic ingredients in traditional Chinese medicines used across China and various other countries in Asia are rising rapidly. Authorities in China have stepped in to control prices but a combination of factors, including the potential profits available in trading TCM ingredients and the growing popularity of TCM globally are driving prices upwards
You may also be interested in...
Traditional Chinese Medicines Seen As Global Growth Opportunity
HONG KONG - Health authorities around the world are working to develop regulatory structures for traditional Chinese medicines
What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 1 of 2)
SHANGHAI - The National Development and Reform Commission, China's state planning agency, charged consumer goods company Unilever a fine of RMB 2 million ($310,000) for price manipulation May 6. The NDRC action was taken in an effort to suppress consumer inflation, but a key takeaway, according to experts, is that multinational companies should be cautious about how they communicate pricing information to the market or they may find themselves in violation of China's Price Law, Anti-Monopoly Law or even foreign antitrust and anti-bribery rules
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).